Product Images Simvastatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Simvastatin NDC 43353-768 by Aphena Pharma Solutions - Tennessee, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bottle label - 43353 768

bottle label - 43353 768

Simvastatin is a drug available in tablet form, with a dosage of 80mg for a box containing 15 tablets. The box has a batch number of "2 PO Ex=3 Z", while the product numbers are N 43353-0768-1 and NDC# 43353-0768-15. The tablets must be stored at a controlled room temperature of 20-25°C, away from minors, and in a container that complies with USP standards. The manufacturer is Blu Caribe located in Dorado, PR, while Aphena Pharma from Cookeville, TN, is the repackager.*

bottle label - 43353 773

bottle label - 43353 773

Simvastatin is a medication presented in a pack of 15 tablets, with a strength of 20mg each. The tablets should be stored at a temperature between 20-25 degrees Celsius and kept out of reach of children. The drug was manufactured by Blu Caribe in Dorado, PR, and repackaged by Aphena Pharma in Cookesville, TN 38506. The batch number is N4335307731, with NDC# 43353-0773-15. No additional information is available.*

Image of chemical structure - simvastatin 1

Image of chemical structure - simvastatin 1

The Effects of Treatment with simvastatin on Major Vascular Events and Major Coronary Events in HPS - simvastatin 2

The Effects of Treatment with simvastatin on Major Vascular Events and Major Coronary Events in HPS - simvastatin 2

This is a statistical report of a medical study with a total of 20,536 patients, out of which 14,573 did not have diabetes mellitus. The report includes the incidence of major vascular events and major coronary events, as well as the LDL and HDL cholesterol levels of the patients in different subgroups. The study compares the use of Simvastatin versus Placebo and presents the risk ratios for each. The report contains triangles that show the point estimates of the relative risk and their 95% confidence intervals.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.